Helix BioPharma Corp. (TSE:HBP – Get Free Report) shares crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$2.18 and traded as high as C$2.25. Helix BioPharma shares last traded at C$2.23, with a volume of 2,878 shares trading hands.
Helix BioPharma Stock Up 1.4%
The firm has a market capitalization of C$170.32 million, a P/E ratio of -24.78 and a beta of 0.22. The business’s 50 day moving average is C$2.18 and its two-hundred day moving average is C$1.43.
Helix BioPharma (TSE:HBP – Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The biopharmaceutical company reported C($0.01) EPS for the quarter. The business had revenue of C$0.31 million for the quarter. As a group, equities analysts anticipate that Helix BioPharma Corp. will post -0.11 earnings per share for the current fiscal year.
About Helix BioPharma
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
Recommended Stories
- Five stocks we like better than Helix BioPharma
- What is a support level?
- Monolithic Power Surges in 2025—Time to Buy or Hold?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Tesla Has Been Trapped in a 10% Range for Months—What’s Going On?
- Following Congress Stock Trades
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
Receive News & Ratings for Helix BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
